Familial Cancer

SJR Rank #6,325H-index: 72SJR: 0.849Best quartile: Q2APC: US$2,990
Journal website: aims, scope and author guidelines
Publisher

Springer Science and Business Media B.V.

Country

Netherlands

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • GeneticsQ2
  • Genetics (clinical)Q2
  • OncologyQ2
  • Cancer ResearchQ3

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Genetic factors in colorectal cancerBRCA gene mutations in cancerCancer Genomics and DiagnosticsColorectal Cancer Screening and DetectionDNA Repair MechanismsColorectal Cancer Treatments and StudiesGenomics and Rare DiseasesGenomic variations and chromosomal abnormalitiesCancer-related Molecular PathwaysOvarian cancer diagnosis and treatment

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs04590135180

Documents per Year

202220250255075100

Detailed Information

ISSN

1573-7292, 1389-9600

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

2.19

References per Document

38.02

Coverage

2001, 2003-2026

Scope

In recent years clinical cancer genetics has become increasingly important. Several events, in particular the developments in DNA-based technology, have contributed to this evolution. Clinical cancer genetics has now matured to a medical discipline which is truly multidisciplinary in which clinical and molecular geneticists work together with clinical and medical oncologists as well as with psycho-social workers. Due to the multidisciplinary nature of clinical cancer genetics most papers are currently being published in a wide variety of journals on epidemiology, oncology and genetics. Familial Cancer provides a forum bringing these topics together focusing on the interests and needs of the clinician. The journal mainly concentrates on clinical cancer genetics. Most major areas in the field shall be included, such as epidemiology of familial cancer, molecular analysis and diagnosis, clinical expression, treatment and prevention, counselling and the health economics of familial cancer.

Metrics from SCImago Journal Rank 2025. View on SCImago